Illumina, Inc. (ILMN) Unveils AI Breakthrough for Rare Disease Diagnosis
Illumina, Inc. (NASDAQ:ILMN) has introduced PromoterAI, a breakthrough AI tool designed to detect disease-causing mutations in the noncoding promoter regions…
Virtual Machine News Platform
Illumina, Inc. (NASDAQ:ILMN) has introduced PromoterAI, a breakthrough AI tool designed to detect disease-causing mutations in the noncoding promoter regions…
AI helps Stony Brook doctors detect heart disease early Long Island Business News Article Source https://libn.com/2025/05/19/ai-helps-stony-brook-doctors-detect-heart-disease-early/
SALT LAKE CITY — It’s long been a goal in medicine to better understand the long trajectories of diseases in…
Scientists at the National Institutes of Health (NIH) recently uncovered how a structure known as low-density lipoprotein (LDL), which transports…
The Biothreats Emergence, Analysis and Communications Network (BEACON) leverages advanced artificial intelligence (AI), large language models (LLMs) and a network…
About 15% of the world’s population — over a billion people — are affected by neurological disorders, from commonly known…
What You Should Know: – Leidos is committing $10M to a five-year collaboration with the University of Pittsburgh’s Computational Pathology…
When Demis Hassabis won the Nobel Prize last year, he celebrated by playing poker with a world champion of chess.…
Pitt and Leidos tap AI to fight disease Axios Article Source https://www.axios.com/local/pittsburgh/2025/04/18/pitt-leidos-use-ai-to-fight-cancer-and-health-disparities
Alzheimer’s disease is a progressive neurodegenerative disorder affecting millions worldwide. The Alzheimer’s Association estimates that over 6 million Americans live…